0,990  0,001  Chemoprotective
0,986  0,001  Antimutagenic
0,974  0,002  Monophenol monooxygenase inhibitor
0,973  0,001  UGT1A9 substrate
0,964  0,002  Genotoxic
0,962  0,002  TNF expression inhibitor
0,962  0,004  Alpha-glucosidase inhibitor
0,955  0,001  NOS2 expression inhibitor
0,952  0,001  Xanthine oxidase inhibitor
0,947  0,002  Chemopreventive
0,944  0,003  Mutagenic
0,934  0,002  Caspase 9 stimulant
0,931  0,001  UGT1A1 substrate
0,927  0,003  Antioxidant
0,923  0,001  Amylase inhibitor
0,924  0,002  Proliferative diseases treatment
0,919  0,001  Antihypoxic
0,899  0,003  Radioprotector
0,898  0,004  Carcinogenic
0,899  0,006  Transcription factor NF kappa B inhibitor
0,895  0,004  Antihypercholesterolemic
0,890  0,003  Cytostatic
0,888  0,003  Cardioprotectant
0,885  0,003  Free radical scavenger
0,875  0,001  Cystathionine beta-synthase inhibitor
0,870  0,001  Melanin inhibitor
0,869  0,002  Sulfotransferase substrate
0,866  0,003  UGT1A6 substrate
0,858  0,002  Carbonic anhydrase XIII inhibitor
0,859  0,003  NOS3 expression inhibitor
0,862  0,009  Apoptosis agonist
0,857  0,005  Cyclophilin D inhibitor
0,857  0,005  Antidiabetic
0,857  0,009  Antiinflammatory
0,834  0,007  Teratogen
0,826  0,004  UDP-glucuronosyltransferase substrate
0,821  0,004  AR expression inhibitor
0,800  0,008  Embryotoxic
0,791  0,001  Antihemorrhagic
0,789  0,004  Hypoglycemic
0,786  0,004  Vasodilator, coronary
0,785  0,004  Angiogenesis stimulant
0,774  0,008  CYP2C9 substrate
0,764  0,002  Antihelmintic (Trematoda)
0,734  0,006  Antibacterial
0,729  0,005  Nitric oxide antagonist
0,728  0,004  DNA damaging
0,721  0,005  Antiparasitic
0,718  0,007  Antithrombotic
0,713  0,006  CTGF expression inhibitor
0,711  0,005  Caspase 3 stimulant
0,709  0,005  Vascular (periferal) disease treatment
0,707  0,004  Skin whitener
0,705  0,003  NOS3 expression enhancer
0,698  0,004  Antihelmintic
0,692  0,005  Apoptosis antagonist
0,691  0,005  Hepatic disorders treatment
0,698  0,013  Antileukemic
0,697  0,018  CYP3A4 substrate
0,682  0,004  Antihypertriglyceridemic
0,675  0,002  Protein kinase stimulant
0,673  0,005  Histamine release inhibitor
0,669  0,003  Antihypotensive
0,667  0,002  AMP-activated protein kinase stimulant
0,666  0,002  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,661  0,003  Mediator release inhibitor
0,660  0,004  Hepatoprotectant
0,652  0,002  Carbonic anhydrase III inhibitor
0,641  0,005  Hypoxia-inducible factor 1 alpha inhibitor
0,639  0,005  Tumour necrosis factor alpha release inhibitor
0,635  0,003  Beta glucuronidase inhibitor
0,639  0,011  CYP1A2 substrate
0,634  0,009  Cytotoxic
0,626  0,007  Amyloid beta aggregation inhibitor
0,617  0,004  ICAM1 expression inhibitor
0,614  0,002  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,613  0,005  Antineoplastic (osteosarcoma)
0,606  0,005  RNA-directed DNA polymerase inhibitor
0,613  0,014  Sensitization
0,627  0,030  Antineoplastic (breast cancer)
0,598  0,004  Non-steroidal antiinflammatory agent
0,591  0,004  Antidote
0,611  0,029  Antineoplastic (lung cancer)
0,586  0,004  VCAM1 expression inhibitor
0,583  0,004  UGT2B4 substrate
0,592  0,012  Antipruritic, allergic
0,587  0,009  Antiamyloidogenic
0,580  0,004  Interleukin 4 antagonist
0,578  0,004  Hemostatic
0,576  0,003  UGT2B15 substrate
0,587  0,015  CYP2C19 substrate
0,589  0,019  Prostate cancer treatment
0,578  0,009  Antipyretic
0,583  0,015  Spasmolytic
0,565  0,002  Nitric-oxide synthase stimulant
0,573  0,011  Ulceration
0,551  0,003  Neurotrophic factor enhancer
0,549  0,003  Cyclooxygenase 3 inhibitor
0,567  0,021  Respiratory analeptic
0,548  0,003  Carbonic anhydrase VI inhibitor
0,549  0,004  Lipid peroxidase inhibitor
0,565  0,023  Cholesterol antagonist
0,553  0,011  Antiprotozoal (Leishmania)
0,567  0,027  Antineoplastic (colorectal cancer)
0,561  0,021  Immunostimulant
0,541  0,005  DNA methylase inhibitor
0,543  0,009  Vasodilator
0,547  0,018  Antineoplastic (cervical cancer)
0,532  0,008  Myocardial infarction treatment
0,539  0,015  Antifungal
0,521  0,004  DNA methyltransferase I inhibitor
0,537  0,024  Immunosuppressant
0,518  0,006  Topoisomerase II inhibitor
0,535  0,029  Antineoplastic (colon cancer)
0,524  0,024  Stroke treatment
0,519  0,019  Antineoplastic (pancreatic cancer)
0,503  0,005  Alkylator
0,504  0,012  Antineoplastic (lymphoma)
0,484  0,008  UGT1A3 substrate
0,489  0,016  CYP1A2 inhibitor
0,477  0,006  Platelet adhesion inhibitor
0,478  0,011  Antineoplastic (liver cancer)
0,470  0,004  NADPH oxidase inhibitor
0,496  0,034  5 Hydroxytryptamine release inhibitor
0,472  0,010  Antineoplastic (sarcoma)
0,464  0,009  Carcinogenic, group 3
0,478  0,023  Antiischemic
0,455  0,005  Antitussive
0,475  0,027  Antineoplastic (melanoma)
0,461  0,013  Radiosensitizer
0,478  0,031  5 Hydroxytryptamine release stimulant
0,464  0,020  Antidiabetic (type 2)
0,468  0,024  Antineoplastic (brain cancer)
0,474  0,031  CYP2C19 inhibitor
0,473  0,031  Antineoplastic (ovarian cancer)
0,455  0,015  Interleukin 2 agonist
0,450  0,012  P-glycoprotein inhibitor
0,441  0,003  Photosensitizer
0,442  0,004  Aldose reductase substrate
0,463  0,025  Antineoplastic (glioma)
0,438  0,016  Peroxidase inhibitor
0,441  0,018  DNA synthesis inhibitor
0,430  0,012  Antiviral (Herpes)
0,420  0,003  DNA repair enzyme inhibitor
0,435  0,019  Antidiabetic symptomatic
0,428  0,013  Cyclic AMP phosphodiesterase inhibitor
0,422  0,008  Antiviral (Influenza)
0,417  0,004  Topoisomerase II alpha inhibitor
0,414  0,003  Antiviral (Influenza B)
0,418  0,010  Interferon gamma antagonist
0,411  0,004  Histone deacetylase stimulant
0,411  0,004  Histone deacetylase SIRT1 stimulant
0,437  0,034  Immunomodulator
0,406  0,004  Hexokinase inhibitor
0,405  0,004  Alcohol dehydrogenase inhibitor
0,431  0,031  Analeptic
0,402  0,003  Carbonic anhydrase XIV inhibitor
0,407  0,011  Antineoplastic (squamous cell carcinoma)
0,399  0,003  Antiviral (Ebola)
0,398  0,006  UDP-glucose 4-epimerase inhibitor
0,397  0,005  Topoisomerase I inhibitor
0,457  0,065  Alzheimer's disease treatment
0,418  0,029  Antineoplastic (non-small cell lung cancer)
0,393  0,005  Antifungal enhancer
0,406  0,018  Antineoplastic (small cell lung cancer)
0,387  0,003  Selectin antagonist
0,429  0,046  Vasodilator, peripheral
0,388  0,007  Insulin secretagoues
0,425  0,043  Bone diseases treatment
0,435  0,055  Antiprotozoal
0,453  0,078  Antineoplastic (solid tumors)
0,403  0,027  Antineoplastic (glioblastoma multiforme)
0,407  0,035  Antiosteoporotic
0,377  0,019  Septic shock treatment
0,362  0,007  Psychosexual dysfunction treatment
0,356  0,007  Aldehyde dehydrogenase inhibitor
0,354  0,006  Expectorant
0,363  0,025  Interleukin agonist
0,350  0,015  Antipruritic, non-allergic
0,334  0,004  Creatine kinase inhibitor
0,334  0,007  Carcinogenic, group 1
0,335  0,015  Peptidyltransferase inhibitor
0,328  0,008  Antineoplastic antibiotic
0,337  0,017  Antineoplastic (carcinoma)
0,354  0,035  Antineoplastic (renal cancer)
0,332  0,013  Alpha-N-acetylglucosaminidase inhibitor
0,354  0,041  Huntington's disease treatment
0,316  0,004  Aldose reductase inhibitor
0,342  0,031  Antiulcerative
0,321  0,011  Glutathione S-transferase substrate
0,313  0,008  Gout treatment
0,313  0,010  Alkaline phosphatase inhibitor
0,330  0,031  Antineoplastic enhancer
0,310  0,012  Acute respiratory distress syndrome (ARDS) treatment
0,301  0,003  Carbonic anhydrase VII inhibitor
0,312  0,015  Liver fibrosis treatment
0,301  0,005  Mannose-6-phosphate isomerase inhibitor
0,299  0,003  Heat shock protein 70 antagonist
0,308  0,017  Protein-tyrosine phosphatase inhibitor
0,308  0,017  Antineoplastic (gastric cancer)
0,306  0,016  Antiviral (Influenza A)
0,333  0,045  Antiprotozoal (Trypanosoma)
0,291  0,016  Interleukin 6 antagonist
0,337  0,063  CYP2D6 substrate
0,328  0,053  Aryl hydrocarbon receptor agonist
0,281  0,008  Dementia treatment
0,324  0,052  Antineoplastic (multiple myeloma)
0,278  0,007  NADH dehydrogenase inhibitor
0,277  0,008  Vascular dementia treatment
0,324  0,060  Lipoprotein disorders treatment
0,266  0,003  Fatty acid synthase inhibitor
0,288  0,026  Thrombolytic
0,289  0,029  UGT2B7 substrate
0,280  0,023  Antihelmintic (Nematodes)
0,270  0,013  SULT1A3 substrate
0,307  0,052  Transcription factor STAT inhibitor
0,269  0,014  Chelator
0,259  0,006  Uric acid excretion stimulant
0,319  0,068  Antimycobacterial
0,329  0,079  Angiogenesis inhibitor
0,313  0,066  Metabolic disease treatment
0,255  0,010  Retinoprotector
0,277  0,033  Dual specificity phosphatase 3 inhibitor
0,267  0,026  Insulin sensitizer
0,250  0,009  Choleretic
0,244  0,004  Xanthine dehydrogenase inhibitor
0,253  0,015  Cell wall synthesis inhibitor
0,254  0,016  DNA polymerase I inhibitor
0,256  0,019  Antidiarrheal
0,242  0,005  Multidrug resistance-associated protein 1 inhibitor
0,242  0,007  HIV-1 integrase (Strand Transfer) inhibitor
0,241  0,007  HIV-1 integrase (3'-Processing) inhibitor
0,283  0,050  Antineoplastic (lymphocytic leukemia)
0,239  0,006  T cell inhibitor
0,260  0,029  Antiviral (Hepatitis)
0,263  0,035  Dual specificity phosphatase inhibitor
0,231  0,005  Thioredoxin inhibitor
0,281  0,055  Antineoplastic (bladder cancer)
0,277  0,054  Pyruvate kinase inhibitor
0,241  0,018  Protein-tyrosine phosphatase 1B inhibitor
0,223  0,007  Carbonic anhydrase XII inhibitor
0,322  0,107  Atherosclerosis treatment
0,220  0,008  NAD(P)H dehydrogenase (quinone) inhibitor
0,221  0,009  Triose-phosphate isomerase inhibitor
0,231  0,019  ATPase inhibitor
0,222  0,011  Antibiotic
0,232  0,022  Antiprotozoal (Coccidial)
0,215  0,004  Phosphodiesterase 6D inhibitor
0,213  0,003  Antibiotic Glycopeptide-like
0,226  0,017  Carcinogenic, group 2B
0,232  0,023  MAO A inhibitor
0,221  0,014  Antifungal (Cryptococcus)
0,214  0,009  Gastritis treatment
0,208  0,005  Toll-Like receptor 4 antagonist
0,215  0,015  CF transmembrane conductance regulator agonist
0,249  0,050  Sedative
0,216  0,022  DNA intercalator
0,275  0,084  Lipoxygenase inhibitor
0,225  0,036  Hair growth stimulant
0,198  0,011  Phosphofructokinase-1 inhibitor
0,239  0,053  Wound healing agent
0,239  0,053  Antialcoholic
0,239  0,061  Antiviral (HIV)
0,318  0,140  Antiarthritic
0,183  0,007  Interleukin 12 antagonist
0,195  0,019  SULT1A1 substrate
0,190  0,016  Antineoplastic, alkylator
0,246  0,074  Platelet antagonist
0,204  0,034  Antirickettsial
0,186  0,015  Telomerase inhibitor
0,177  0,009  CDC25A inhibitor
0,189  0,020  Anticataract
0,178  0,011  Transcription factor NF kappa B stimulant
0,185  0,019  UGT2B1 substrate
0,182  0,016  Antispirochetal
0,230  0,070  Interleukin antagonist
0,276  0,116  Antiprotozoal (Plasmodium)
0,189  0,030  Antiviral (Hepatitis B)
0,159  0,002  Arginase inhibitor
0,193  0,036  M18 aspartyl aminopeptidase inhibitor
0,176  0,020  Mucolytic
0,173  0,017  Chronic obstructive bronchitis treatment
0,157  0,002  Sodium/glucose cotransporter inhibitor
0,196  0,044  Neuropathy treatment
0,168  0,021  Antineoplastic (uterine cancer)
0,157  0,011  Estrogen agonist
0,192  0,047  Antiviral (Hepatitis C)
0,184  0,038  Acetylcholinesterase inhibitor
0,147  0,002  Cholesterol absorption inhibitor
0,268  0,123  Antineoplastic (endocrine cancer)
0,162  0,020  Sphingomyelinase inhibitor
0,147  0,006  Na+ K+ transporting ATPase inhibitor
0,160  0,020  Estrogen antagonist
0,147  0,008  Neuraminidase (influenza) inhibitor
0,158  0,019  Carcinogenic, group 2A
0,198  0,059  VEGF expression inhibitor
0,146  0,008  Antiviral (Dengue virus)
0,188  0,051  Antineoplastic (bone cancer)
0,156  0,019  Transcription factor STAT6 inhibitor
0,144  0,007  Phosphodiesterase VI inhibitor
0,143  0,008  Phosphorylase inhibitor
0,136  0,002  Sodium/glucose cotransporter 2 inhibitor
0,243  0,113  12-Lipoxygenase inhibitor
0,184  0,055  Muscular dystrophy treatment
0,168  0,039  Hearing loss treatment
0,144  0,017  SULT1E1 substrate
0,282  0,155  Antiparkinsonian
0,130  0,006  Antimycoplasmal
0,137  0,015  Interleukin 5 antagonist
0,130  0,008  Neuraminidase inhibitor
0,207  0,089  Hypolipemic
0,132  0,014  Lipase inhibitor
0,119  0,002  Sodium/glucose cotransporter 1 inhibitor
0,129  0,014  Postmenopausal disorders treatment
0,168  0,053  MAO inhibitor
0,178  0,064  Phospholipase C inhibitor
0,164  0,055  Antidiabetic (type 1)
0,168  0,060  UGT2B9 substrate
0,143  0,034  HDL-cholesterol increasing
0,125  0,017  ATPase (Vacuolar H+) inhibitor
0,136  0,030  Breast cancer-resistant protein inhibitor
0,164  0,058  Antinephritic
0,261  0,156  15-Lipoxygenase inhibitor
0,157  0,052  Adenylate cyclase stimulant
0,108  0,005  Alpha-mannosidase inhibitor
0,155  0,054  Cyclooxygenase 1 inhibitor
0,145  0,045  Growth stimulant
0,144  0,044  Vanilloid 1 agonist
0,175  0,078  Diabetic nephropathy treatment
0,255  0,158  CYP2C9 inhibitor
0,115  0,019  Thioredoxin reductase inhibitor
0,100  0,006  Mannosidase inhibitor
0,114  0,020  Interferon agonist
0,107  0,014  CDC25B inhibitor
0,097  0,005  Glucose-6-phosphate isomerase inhibitor
0,147  0,055  Toll-Like receptor 2 antagonist
0,095  0,003  Antibiotic Aminoglycoside-like
0,121  0,032  Actinic keratosis treatment
0,102  0,013  Protein 50S ribosomal subunit inhibitor
0,161  0,072  Cystic fibrosis treatment
0,120  0,032  Estrogen receptor beta antagonist
0,101  0,014  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,093  0,008  Glucose-6-phosphate translocase inhibitor
0,089  0,004  Protein 30S ribosomal subunit inhibitor
0,106  0,022  HIV-1 integrase inhibitor
0,105  0,021  Narcotic antagonist
0,100  0,016  Antidote, heavy metal
0,089  0,005  Heparanase inhibitor
0,137  0,054  Cell adhesion inhibitor
0,150  0,070  Cyclooxygenase inhibitor
0,114  0,033  Antiviral (Rhinovirus)
0,122  0,044  Electron transport complex I inhibitor
0,160  0,083  UGT2B10 substrate
0,136  0,061  Antibacterial (Helicobacter pylori)
0,087  0,013  Estrogen receptor beta agonist
0,156  0,083  UGT1A4 substrate
0,081  0,009  Adenosine deaminase inhibitor
0,096  0,027  Carbonic anhydrase VA inhibitor
0,108  0,042  Protein kinase C zeta inhibitor
0,134  0,070  Antiacne
0,089  0,026  Antitreponemal
0,156  0,095  Diabetic retinopathy treatment
0,143  0,083  Diuretic
0,108  0,048  UGT2B11 substrate
0,081  0,021  Nitric oxide donor
0,090  0,031  Carbonic anhydrase V inhibitor
0,150  0,091  Muscle relaxant
0,129  0,071  Cyclooxygenase 2 inhibitor
0,192  0,135  Antituberculosic
0,203  0,146  5 Hydroxytryptamine uptake stimulant
0,080  0,024  Interferon inducer
0,062  0,006  Nucleoside transporters inhibitor
0,094  0,038  D-Ala-D-Ala ligase inhibitor
0,071  0,016  Topoisomerase II beta inhibitor
0,132  0,078  Neurotrophic factor
0,159  0,105  Anesthetic general
0,078  0,025  Maillard reaction inhibitor
0,076  0,025  Protein kinase C eta inhibitor
0,094  0,044  Antiviral (Trachoma)
0,097  0,049  Restless leg syndrome treatment
0,098  0,053  Falcipain 2 inhibitor
0,100  0,055  Falcipain inhibitor
0,115  0,071  Adenylate cyclase inhibitor
0,227  0,183  Antineoplastic (non-Hodgkin's lymphoma)
0,122  0,078  Tubulin antagonist
0,061  0,018  Equilibrative nucleoside transport protein inhibitor
0,073  0,034  Aryl hydrocarbon receptor antagonist
0,054  0,016  Estrogen receptor alpha agonist
0,063  0,025  Leukotriene B4 antagonist
0,085  0,049  Glycine receptor antagonist
0,040  0,004  Vanilloid 2 agonist
0,144  0,108  Amyloid beta precursor protein antagonist
0,053  0,019  Neuraminidase (Influenza A) inhibitor
0,099  0,065  5-Lipoxygenase inhibitor
0,100  0,067  Carbonic anhydrase XV inhibitor
0,094  0,061  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,056  0,024  Squalene epoxidase inhibitor
0,060  0,029  Adenine nucleotide translocase inhibitor
0,037  0,006  Dopamine D1 agonist
0,105  0,077  Nav1.5 sodium channel blocker
0,206  0,182  GST M1-1 substrate
0,105  0,081  Cholesterol synthesis inhibitor
0,060  0,037  Carbonic anhydrase IX inhibitor
0,066  0,042  Carbonic anhydrase inhibitor
0,027  0,004  Telomerase stimulant
0,081  0,059  Glutathione S-transferase inhibitor
0,074  0,052  Adenosine A3 receptor antagonist
0,059  0,037  Lipocortins synthesis agonist
0,103  0,081  Antiviral (SARS coronavirus)
0,103  0,081  Antiviral (Coronavirus)
0,099  0,078  DOPA decarboxylase inhibitor
0,031  0,010  Toll-Like receptor 4 agonist
0,024  0,005  Antibiotic Anthracycline-like
0,036  0,018  Catechol O-methyltransferase inhibitor
0,050  0,034  Factor III inhibitor
0,031  0,014  1,3-Beta-glucan synthase inhibitor
0,195  0,179  CYP3A4 inhibitor
0,084  0,069  Aminoacyl-tRNA synthetase inhibitor
0,143  0,128  Sepsis treatment
0,031  0,017  Uridine phosphorylase inhibitor
0,048  0,035  Antiviral (Herpesvirus 3, Human)
0,121  0,108  Skeletal muscle relaxant
0,073  0,061  Estrogen receptor alpha antagonist
0,108  0,098  Bone formation stimulant
0,024  0,017  Adenosine A1 receptor agonist
0,137  0,131  LDLR expression enhancer
0,031  0,026  Estrogen-related receptor beta antagonist
0,111  0,107  Papain-like protease (SARS coronavirus) inhibitor
0,098  0,095  Microtubule formation inhibitor
0,060  0,056  Cyclin B3 inhibitor
0,083  0,081  Glutamate release inhibitor
0,010  0,009  Purinergic P2Y2 agonist
0,020  0,019  GRP78 expression inhibitor

